UFP Technologies – $600M Revenue, Focus on Medical Devices

By Tamara Parker • Tuesday, June 10 10:18 • Permanent Link

The press release from UFP Technologies, Inc. (Ticker: UFPT) provides an insight into the company's financial performance and growth strategy.

In terms of financials, the company's annual revenue stands at around $600 million as of June 2025, with a market capitalization of approximately $1.85 billion. The press release also mentions that the company has completed seven acquisitions since 2021.

UFP Technologies is focused on the medical device market, and its customers include 26 of the top 30 largest medical device manufacturers in the world. The press release states that the global medical device market is valued at $518 billion, with a forecasted compound annual growth rate (CAGR) of 6.3% from 2024 to 2032.

The company's revenue mix through April 2025 shows that 58% comes from devices, 26% from revascularization and surgical (RAS), and 16% from packaging.

The press release highlights the opportunities in high-growth niche segments, with a focus on single-use, single-patient products, customer-funded development, and leveraging technology differentiation. The company aims to expand its business with existing customers by offering complementary products and services.

UFP Technologies' acquisition growth strategy is centered on higher-growth, higher-margin MedTech opportunities that create value. The company aims for acquisitions to be accretive within the first year and has a management team with experience in completing 19 acquisitions.

The press release also emphasizes the company's proven acquisition integration model and its successful transition from diversified industrial to MedTech sales, showcasing a significant increase in MedTech sales over time.

In terms of competitive advantage, UFP Technologies emphasizes its advanced systems, in-house custom equipment manufacturing capabilities, numerous patents, and a global footprint, which it views as a competitive edge over smaller companies with limited resources.

As a result of these announcements, the company's shares have moved 0.31% on the market, and are now trading at a price of $238.19. Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.